Comparative Study
[Treatment of diabetes insipidus with synthetic vasopressin derivatives (effect of 1-deamino-8-D-arginine vasopressin and 1-deamino-valine-8-D-arginine vasopressin)]
[Article in
Hungarian]
- PMID: 7383655
Item in Clipboard
Comparative Study
[Treatment of diabetes insipidus with synthetic vasopressin derivatives (effect of 1-deamino-8-D-arginine vasopressin and 1-deamino-valine-8-D-arginine vasopressin)]
[Article in
Hungarian]
Orv Hetil.
.
No abstract available
Similar articles
-
1-deamino-/4-valine-8-D-arginine/-vasopressin (dVDAVP), a new synthetic vasopressin analog for treating diabetes insipidus.Int J Clin Pharmacol Ther Toxicol. 1982 Jan;20(1):39-43. Int J Clin Pharmacol Ther Toxicol. 1982. PMID: 7056603
-
Effects of vasopressin analogues (DDAVP, DVDAVP) in the form of sublingual tablets in central diabetes insipidus.Int J Clin Pharmacol Ther Toxicol. 1981 Feb;19(2):63-8. Int J Clin Pharmacol Ther Toxicol. 1981. PMID: 7216552
-
Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.Acta Med Acad Sci Hung. 1975;32(1):75-84. Acta Med Acad Sci Hung. 1975. PMID: 1233863
-
[Treatment of diabetes insipidus].Minerva Endocrinol. 1990 Jan-Mar;15(1):95-9. Minerva Endocrinol. 1990. PMID: 2274021 Review. Italian.
-
Diabetes insipidus: clinical and basic aspects.Pediatr Endocrinol Rev. 2006 Dec;4 Suppl 1:60-5. Pediatr Endocrinol Rev. 2006. PMID: 17261971 Review.
Cited by
-
Altered agonist sensitivity of a mutant v2 receptor suggests a novel therapeutic strategy for nephrogenic diabetes insipidus.Mol Endocrinol. 2014 May;28(5):634-43. doi: 10.1210/me.2013-1424. Epub 2014 Mar 14. Mol Endocrinol. 2014. PMID: 24628417 Free PMC article.
-
V2 vasopressin receptor mutations: future personalized therapy based on individual molecular biology.Front Endocrinol (Lausanne). 2023 May 24;14:1173601. doi: 10.3389/fendo.2023.1173601. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37293495 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical